Analyst	Recommendation	Action	Price target	Projected	Date
Sergey Pigarev Freedom Capital Markets	Hold	Maintained	$15.00	+14.2%	11/06/2026
Eddie Kim Barclays	Hold	Downgraded	$14.00	+6.5%	11/05/2026
Derek Podhaizer Piper Sandler	Sell	Maintained	$15.00	+14.2%	11/04/2026
Atidrip Modak Goldman Sachs	Buy	Maintained	$19.00	+44.6%	10/13/2026

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	382.13M	367.57M	393.18M	439.94M
Cost of goods sold	286.56M	297.61M	311.16M	344.71M
Cost of revenue	286.56M	297.61M	311.16M	344.71M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	17.53M	18.32M	19.21M	17.84M
Operating expense	71.31M	63.72M	65.00M	71.12M
Total operating expenses	357.86M	361.33M	376.16M	415.84M
Operating income	24.26M	6.24M	17.02M	24.11M
Other non operating income	-1.47M	776.00K	-688.00K	163.00K
EBT including unusual items	13.38M	5.18M	10.18M	5.00M
EBT excluding unusual items	24.19M	8.70M	16.39M	23.76M
Income tax expense	7.60M	6.22M	8.15M	10.20M
Effective tax rate	56.85%	119.95%	80.08%	203.98%
Other operating expenses	-	-	-	-
Net income	5.77M	-1.03M	2.03M	-5.20M
Net profit margin	1.51%	-0.28%	0.52%	-1.18%
Earnings per share	0.21	0.09	0.15	0.19
Interest and investment income	-	-	-	-
Interest expense	-2.44M	-1.55M	-2.71M	-5.80M
Net interest expenses	-2.44M	-1.55M	-2.71M	-5.80M
Depreciation and amortization charges	53.77M	45.40M	45.79M	53.28M
EBITDA	78.04M	51.64M	62.82M	77.39M
Gain or loss from assets sale	-	-	-	-

Ask anything